We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

26 hedge funds and large institutions have $2.05M invested in Edesa Biotech in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

18% more funds holding

Funds holding: 22 → 26 (+4)

0.4% more ownership

Funds ownership: 1.21% → 1.6% (+0.4%)

41% less capital invested

Capital invested by funds: $3.49M → $2.05M (-$1.44M)

Holders
26
Holders Change
+4
Holders Change %
+18.18%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VCIM
Velan Capital Investment Management
Georgia
+$586K
2
LCM
Lynwood Capital Management
Ontario, Canada
+$247K
3
Two Sigma Investments
Two Sigma Investments
New York
+$39.8K
4
Renaissance Technologies
Renaissance Technologies
New York
+$26.1K
5
CM
CM Management
Florida
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$32.9K
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$11.8K
3
Morgan Stanley
Morgan Stanley
New York
-$2.96K
4
Osaic Holdings
Osaic Holdings
Arizona
-$146
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$84
Name Holding Trade Value Shares
Change 		Change in
Stake
VCIM
1
Velan Capital Investment Management
Georgia
$1.17M +$586K +56,104 +44%
CM
2
CM Management
Florida
$296K +$18.2K +1,747 +4%
LCM
3
Lynwood Capital Management
Ontario, Canada
$262K +$247K +23,665 +136%
Vanguard Group
4
Vanguard Group
Pennsylvania
$101K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$79.1K – – –
State Street
6
State Street
Massachusetts
$40.1K – – –
Two Sigma Investments
7
Two Sigma Investments
New York
$24.4K +$39.8K +3,815 New
Northern Trust
8
Northern Trust
Illinois
$20.6K +$10.7K +1,027 +47%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$16.2K – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$16K +$26.1K +2,500 New
SS
11
Simplicity Solutions
Minnesota
$9.12K +$14.9K +1,429 New
TRCT
12
Tower Research Capital (TRC)
New York
$9K +$4.76K +456 +50%
UBS Group
13
UBS Group
Switzerland
$5.2K +$8.46K +810 +16,200%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1K -$84 -8 -4%
TWC
15
TD Waterhouse Canada
Ontario, Canada
$970 – – –
Fifth Third Bancorp
16
Fifth Third Bancorp
Ohio
$638 – – –
BlackRock
17
BlackRock
New York
$472 – – –
GRP
18
Global Retirement Partners
California
$196 +$261 +25 New
FDCDDQ
19
Federation des caisses Desjardins du Quebec
Quebec, Canada
$123 – – –
Wells Fargo
20
Wells Fargo
California
$100 +$52 +5 +45%
National Bank of Canada
21
National Bank of Canada
Quebec, Canada
$51 -$11.8K -1,135 -99%
PNC Financial Services Group
22
PNC Financial Services Group
Pennsylvania
$32 +$52 +5 New
AWM
23
AllSquare Wealth Management
New York
$9 – – –
Credit Agricole
24
Credit Agricole
France
$8 – – –
Osaic Holdings
25
Osaic Holdings
Arizona
$4 -$146 -14 -93%
1
2

EDSA Hedge Fund Activity: Q1 2023 in Review

26 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2023, worth a combined $2.05M — down 41% from $3.49M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new EDSA positions and 2 closed out — a net gain of 4 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Velan Capital Investment Management, adding an estimated $586K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $32.9K sold.

  • 26 institutional investors held Edesa Biotech (EDSA) as of Q1 2023, up from 22 in Q4 2022.
  • Funds reported $2.05M of Edesa Biotech stock for Q1 2023, down 41% quarter-over-quarter.
  • 6 funds opened new Edesa Biotech positions in Q1 2023 and 2 closed out, a net change of +4 holders.
  • The largest Edesa Biotech buyer in Q1 2023 was Velan Capital Investment Management, an estimated $586K added.
  • The largest Edesa Biotech seller in Q1 2023 was Susquehanna International Group, an estimated $32.9K sold.

Based on aggregated 13F filings for Q1 2023.